Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
The global Erythromycin Thiocyanate API market was valued at US$ 1571 million in 2023 and is anticipated to reach US$ 2274 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
North American market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erythromycin Thiocyanate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Erythromycin Thiocyanate API include Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erythromycin Thiocyanate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin Thiocyanate API.
The Erythromycin Thiocyanate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erythromycin Thiocyanate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythromycin Thiocyanate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Yili Chuannig Biotechnology
Yichang East Sunshine
Alebi Pharma
META Pharmaceuticals
Anuh Pharma
HEC Group
AbbVie
by Type
Industrial Grade
Feed Grade
Pharmaceutical Grade
by Application
Erythromycin Synthesis
Feed Additive
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythromycin Thiocyanate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Erythromycin Thiocyanate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Erythromycin Thiocyanate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Erythromycin Thiocyanate API 麻豆原创 Overview
1.1 Product Definition
1.2 Erythromycin Thiocyanate API by Type
1.2.1 Global Erythromycin Thiocyanate API 麻豆原创 Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Industrial Grade
1.2.3 Feed Grade
1.2.4 Pharmaceutical Grade
1.3 Erythromycin Thiocyanate API by Application
1.3.1 Global Erythromycin Thiocyanate API 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Erythromycin Synthesis
1.3.3 Feed Additive
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Erythromycin Thiocyanate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Erythromycin Thiocyanate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Erythromycin Thiocyanate API 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Erythromycin Thiocyanate API Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Erythromycin Thiocyanate API Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Erythromycin Thiocyanate API, Industry Ranking, 2022 VS 2023
2.4 Global Erythromycin Thiocyanate API 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Erythromycin Thiocyanate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Erythromycin Thiocyanate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Erythromycin Thiocyanate API, Product Offered and Application
2.8 Global Key Manufacturers of Erythromycin Thiocyanate API, Date of Enter into This Industry
2.9 Erythromycin Thiocyanate API 麻豆原创 Competitive Situation and Trends
2.9.1 Erythromycin Thiocyanate API 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Erythromycin Thiocyanate API Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Erythromycin Thiocyanate API Production by Region
3.1 Global Erythromycin Thiocyanate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Erythromycin Thiocyanate API Production Value by Region (2019-2030)
3.2.1 Global Erythromycin Thiocyanate API Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Erythromycin Thiocyanate API by Region (2025-2030)
3.3 Global Erythromycin Thiocyanate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Erythromycin Thiocyanate API Production by Region (2019-2030)
3.4.1 Global Erythromycin Thiocyanate API Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Erythromycin Thiocyanate API by Region (2025-2030)
3.5 Global Erythromycin Thiocyanate API 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Erythromycin Thiocyanate API Production and Value, Year-over-Year Growth
3.6.1 North America Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2019-2030)
4 Erythromycin Thiocyanate API Consumption by Region
4.1 Global Erythromycin Thiocyanate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Erythromycin Thiocyanate API Consumption by Region (2019-2030)
4.2.1 Global Erythromycin Thiocyanate API Consumption by Region (2019-2030)
4.2.2 Global Erythromycin Thiocyanate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Erythromycin Thiocyanate API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Erythromycin Thiocyanate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Erythromycin Thiocyanate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Erythromycin Thiocyanate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Erythromycin Thiocyanate API Production by Type (2019-2030)
5.1.1 Global Erythromycin Thiocyanate API Production by Type (2019-2024)
5.1.2 Global Erythromycin Thiocyanate API Production by Type (2025-2030)
5.1.3 Global Erythromycin Thiocyanate API Production 麻豆原创 Share by Type (2019-2030)
5.2 Global Erythromycin Thiocyanate API Production Value by Type (2019-2030)
5.2.1 Global Erythromycin Thiocyanate API Production Value by Type (2019-2024)
5.2.2 Global Erythromycin Thiocyanate API Production Value by Type (2025-2030)
5.2.3 Global Erythromycin Thiocyanate API Production Value 麻豆原创 Share by Type (2019-2030)
5.3 Global Erythromycin Thiocyanate API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Erythromycin Thiocyanate API Production by Application (2019-2030)
6.1.1 Global Erythromycin Thiocyanate API Production by Application (2019-2024)
6.1.2 Global Erythromycin Thiocyanate API Production by Application (2025-2030)
6.1.3 Global Erythromycin Thiocyanate API Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Erythromycin Thiocyanate API Production Value by Application (2019-2030)
6.2.1 Global Erythromycin Thiocyanate API Production Value by Application (2019-2024)
6.2.2 Global Erythromycin Thiocyanate API Production Value by Application (2025-2030)
6.2.3 Global Erythromycin Thiocyanate API Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Erythromycin Thiocyanate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Yili Chuannig Biotechnology
7.1.1 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Company Information
7.1.2 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Portfolio
7.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Yili Chuannig Biotechnology Main Business and 麻豆原创s Served
7.1.5 Yili Chuannig Biotechnology Recent Developments/Updates
7.2 Yichang East Sunshine
7.2.1 Yichang East Sunshine Erythromycin Thiocyanate API Company Information
7.2.2 Yichang East Sunshine Erythromycin Thiocyanate API Product Portfolio
7.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Yichang East Sunshine Main Business and 麻豆原创s Served
7.2.5 Yichang East Sunshine Recent Developments/Updates
7.3 Alebi Pharma
7.3.1 Alebi Pharma Erythromycin Thiocyanate API Company Information
7.3.2 Alebi Pharma Erythromycin Thiocyanate API Product Portfolio
7.3.3 Alebi Pharma Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Alebi Pharma Main Business and 麻豆原创s Served
7.3.5 Alebi Pharma Recent Developments/Updates
7.4 META Pharmaceuticals
7.4.1 META Pharmaceuticals Erythromycin Thiocyanate API Company Information
7.4.2 META Pharmaceuticals Erythromycin Thiocyanate API Product Portfolio
7.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 META Pharmaceuticals Main Business and 麻豆原创s Served
7.4.5 META Pharmaceuticals Recent Developments/Updates
7.5 Anuh Pharma
7.5.1 Anuh Pharma Erythromycin Thiocyanate API Company Information
7.5.2 Anuh Pharma Erythromycin Thiocyanate API Product Portfolio
7.5.3 Anuh Pharma Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Anuh Pharma Main Business and 麻豆原创s Served
7.5.5 Anuh Pharma Recent Developments/Updates
7.6 HEC Group
7.6.1 HEC Group Erythromycin Thiocyanate API Company Information
7.6.2 HEC Group Erythromycin Thiocyanate API Product Portfolio
7.6.3 HEC Group Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 HEC Group Main Business and 麻豆原创s Served
7.6.5 HEC Group Recent Developments/Updates
7.7 AbbVie
7.7.1 AbbVie Erythromycin Thiocyanate API Company Information
7.7.2 AbbVie Erythromycin Thiocyanate API Product Portfolio
7.7.3 AbbVie Erythromycin Thiocyanate API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 AbbVie Main Business and 麻豆原创s Served
7.7.5 AbbVie Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Erythromycin Thiocyanate API Industry Chain Analysis
8.2 Erythromycin Thiocyanate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Erythromycin Thiocyanate API Production Mode & Process
8.4 Erythromycin Thiocyanate API Sales and 麻豆原创ing
8.4.1 Erythromycin Thiocyanate API Sales Channels
8.4.2 Erythromycin Thiocyanate API Distributors
8.5 Erythromycin Thiocyanate API Customers
9 Erythromycin Thiocyanate API 麻豆原创 Dynamics
9.1 Erythromycin Thiocyanate API Industry Trends
9.2 Erythromycin Thiocyanate API 麻豆原创 Drivers
9.3 Erythromycin Thiocyanate API 麻豆原创 Challenges
9.4 Erythromycin Thiocyanate API 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Yili Chuannig Biotechnology
Yichang East Sunshine
Alebi Pharma
META Pharmaceuticals
Anuh Pharma
HEC Group
AbbVie
听
听
*If Applicable.